US Government and Ebola

Death of Her Majesty Queen Elizabeth II

Find out more

Death of Her Majesty Queen Elizabeth II

The staff at Franks & Co were saddened to learn of the death of Her Majesty Queen Elizabeth II. Our thoughts are with His Majesty King Charles III and the rest of the Royal Family.

The United Kingdom is now officially in a period of mourning until after the Queen’s state funeral which is to be held on Monday 19 September. Normal day-to-day business will continue throughout this period.

The UK government has declared the day of the funeral to be a national Bank Holiday, so the United Kingdom Intellectual Property Office will be closed on Monday 19 September.

The United Kingdom Intellectual Property Office’s official guidance on bank holidays is given below:

The office is deemed to be closed on weekends, Good Friday, Christmas Day and all England and Wales bank holidays for all types of business, except for the filing of new applications not claiming priority. If documents are filed for these types of business at times when the office is deemed to be closed, they will receive an official filing date of the next working day.

Any official time period which expires on a weekend or any other day on which the office is closed is extended to the next working day.

Skip navigation

The WHO is searching for means by which it can prevent the spread of Ebola and allow the production of experimental vaccines on a larger scale.

The Ebola virus was discovered by the Belgian Scientist Peter Piot in 1976. However, a small study of the patent literature shows that it is not Peter Piot but the US government that has an impressive portfolio relating to the Ebola virus sequences and antibodies which bind to Ebola proteins for use as a possible vaccine therapy.

The US patent 6,630,144B in the name of the United States Army Medical Research Institute of Infectious Diseases, describes a mixture of antibodies against Ebola.

European Patent EP 1 608 393B, also in name of the US Army describes several Ebola peptides which can be used for the generation of a vaccine.

Vanda Pichova previously worked as one of two European Patent Attorneys in the patents department of Innogenetics in Belgium, prior to joining Franks & Co.

Article Published October 8, 2014